Oulu trial: vibrations and nitroglycerin raise blood amyloid

Researchers from the University of Oulu in Finland tested a non-invasive protocol on 29 healthy adult participants without cognitive impairments to stimulate waste clearance from the brain, according to lomazoma.com lomazoma.com. The experimental therapy combined whole-body mechanical vibrations with a vasodilator to promote fluid dynamics through the glymphatic system lomazoma.com. The findings were published in the journal Nature Communications lomazoma.com.

During the trial sessions, subjects lay for nearly 40 minutes on a specialized mattress delivering whole-body vibrations at frequencies between 22 and 50 Hertz lomazoma.com. Simultaneously, participants received sublingual nitroglycerin: two 0.5-milligram tablets administered roughly 20 minutes apart lomazoma.com. Nitroglycerin dilates blood vessels, which researchers hypothesized would drive fluid movement through brain tissue when paired with mechanical oscillations lomazoma.com.

Blood protein changes

Following the combined session, blood levels of three brain-derived proteins increased with statistical significance: amyloid-beta 40, amyloid-beta 42, and glial fibrillary acidic protein (GFAP) lomazoma.com. Amyloid-beta 42, a key biomarker associated with Alzheimer's disease pathology, showed an average blood concentration increase of 35 percent lomazoma.com. Imaging scans also registered shifts in cerebrospinal fluid dynamics lomazoma.com.

Control sessions spaced at least a week apart tested each component independently on the same cohort lomazoma.com. Brain scans revealed that vibration alone or nitroglycerin alone produced less than half the measured effect of the combined intervention lomazoma.com.

Limitations and next steps

Outside researchers noted that increased systemic levels do not definitively prove accelerated brain clearance lomazoma.com. An alternative explanation is that the protocol slows the degradation of amyloid-beta 42 in the liver lomazoma.com. Furthermore, brain scans reflect fluid flow indirectly rather than tracing solute elimination directly lomazoma.com.

The intervention was generally well tolerated, though six subjects reported nausea or headaches lomazoma.com. Lead researcher Vesa Kiviniemi warned against self-experimentation due to the hypotensive risks of nitroglycerin, which can cause fainting lomazoma.com. The team plans an upcoming trial involving 60 participants with mild cognitive impairment or Alzheimer's disease to test whether the acute effect reproduces in affected populations lomazoma.com.

University of Oulu combines vibrations and nitroglycerin to clear brain proteins in trial

Blood protein changes

Limitations and next steps

Sources · 1

Read also

Five South Korean healthcare startups complete Silicon Valley bootcamp